Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan · Delayed Price · Currency is TWD 43.50
+2.20 (5.33%)
Apr 17, 2026, 1:30 PM CST
Easywell Biomedicals Market Cap
Easywell Biomedicals has a market cap or net worth of 5.42 billion as of April 17, 2026. Its market cap has decreased by -38.66% in one year.
Market Cap
5.42B
Enterprise Value
5.41B
Revenue
597.41M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.50
Market Cap Chart
Since February 8, 2007, Easywell Biomedicals's market cap has increased from 447.40M to 5.42B, an increase of 1,112.34%. That is a compound annual growth rate of 13.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 5.42B | 21.51% |
| Dec 31, 2025 | 4.46B | -43.03% |
| Dec 31, 2024 | 7.84B | 63.75% |
| Dec 29, 2023 | 4.79B | 160.70% |
| Dec 30, 2022 | 1.84B | -29.34% |
| Dec 30, 2021 | 2.60B | 7.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Standard Chemical & Pharmaceutical | 11.26B |
| Alar Pharmaceuticals | 11.22B |
| Formosa Laboratories | 6.34B |
| LIWANLI Innovation | 6.11B |
| SCI Pharmtech | 5.80B |
| Orient Pharma | 5.75B |
| Orient EuroPharma | 4.11B |
| Merdury Biopharmaceutical | 3.43B |